Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 29351-29400 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT06271213
The Gut-Lung Axis and Respiratory Illness in Children
N/A
Recruiting
150 participants
Started: Feb 4, 2024 · Completed: May 1, 2028
6 conditions
2 sponsors
1 location
NCT06893419
Geriatric Telemanagement of HEALTH Conditions in Nursing Home Residents Recently Discharged From the Hospital- GET HEALTH-I
NA
Recruiting
102 participants
Started: Feb 4, 2024 · Completed: Mar 31, 2026
1 condition
2 sponsors
1 location
NCT06323681
Pegylated Interferon α in Previously Interferon-treated CHB(Leading Study)
NA
Recruiting
2,016 participants
Started: Feb 4, 2024 · Completed: Aug 31, 2027
1 condition
1 sponsor
1 location
NCT05513716
Molecular Characterisation of Colorectal Cancer Peritoneal Metastases
N/A
Recruiting
200 participants
Started: Feb 4, 2024 · Completed: Jul 3, 2025
1 condition
2 sponsors
1 location
NCT06086457
PD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal Cancer
PHASE3
Recruiting
436 participants
Started: Feb 4, 2024 · Completed: Aug 28, 2029
1 condition
17 sponsors
1 location
NCT05364788
Molecular Characterisation of Appendiceal Cancer
N/A
Recruiting
100 participants
Started: Feb 4, 2024 · Completed: Jul 3, 2025
1 condition
2 sponsors
1 location
NCT06797414
Comparison of Pilate Exercises With and Without Whole Body Vibration in Patient With Upper Cross Syndrome
NA
Recruiting
56 participants
Started: Feb 4, 2024 · Completed: Feb 7, 2025
1 condition
1 sponsor
1 location
NCT06299800
Phenotyping Patients With Type 2 Diabetes Mellitus and Cancer
N/A
Recruiting
779 participants
Started: Feb 4, 2024 · Completed: Feb 4, 2025
2 conditions
1 sponsor
1 location
NCT05968157
MIRAI-MRI: Comparing Screening MRI for Patients at High Risk for Breast Cancer Identified by Mirai and Tyrer-Cuzick
NA
Recruiting
200 participants
Started: Feb 4, 2024 · Completed: Sep 30, 2027
1 condition
3 sponsors
1 location
NCT06243354
Phase 1/2 Study of HYP-2090PTSA in Patients With Advanced Solid Tumors Harboring KRAS Mutation
PHASE1/PHASE2
Recruiting
257 participants
Started: Feb 4, 2024 · Completed: Dec 31, 2025
3 conditions
1 sponsor
6 locations
NCT06732765
Comparative Effects of Eloda With/Without Muscle Energy Technique in Patient With Quadratus Lumborum Syndrome
NA
Recruiting
62 participants
Started: Feb 4, 2024 · Completed: Jan 15, 2025
1 condition
1 sponsor
1 location
NCT06340165
A Real-world Efficacy and Safety Study of Amlotinib for HER2-negative Advanced Breast Cancer
N/A
Recruiting
153 participants
Started: Feb 4, 2024 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT06273137
Positive Affect Treatment for Adolescents with Early Life Adversity
NA
Recruiting
300 participants
Started: Feb 3, 2024 · Completed: Oct 31, 2030
1 condition
1 sponsor
1 location
NCT05865561
Identification of Volatile Organic Compounds (VOCs) as Biopredictors of Epileptic Seizures
N/A
Recruiting
100 participants
Started: Feb 3, 2024 · Completed: Oct 3, 2025
1 condition
1 sponsor
1 location
NCT05487053
The Impact of Single-shot Adductor Canal Block Versus Continuous Femoral Nerve Block on Rehabilitation After Total Knee Replacement
NA
Recruiting
220 participants
Started: Feb 3, 2024 · Completed: Jul 1, 2028
2 conditions
1 sponsor
1 location
NCT06329999
A Prospective, Multicenter, and Exploratory Study of CMGV in the Treatment of Recurrent Adult AML and MDS-EB-2/Elder AML
NA
Recruiting
78 participants
Started: Feb 3, 2024 · Completed: Dec 31, 2027
3 conditions
18 sponsors
1 location
NCT06360718
Effects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on Parental Stress.
NA
Recruiting
140 participants
Started: Feb 3, 2024 · Completed: Jul 1, 2026
1 condition
1 sponsor
1 location
NCT06303128
Penicillin Allergy Delabeling After a One-Dose Versus Two-Dose Graded Direct Oral Challenge
PHASE3
Recruiting
380 participants
Started: Feb 3, 2024 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT06225648
Threonine Requirement in Adults >60 Years of Age
NA
Recruiting
40 participants
Started: Feb 3, 2024 · Completed: Sep 30, 2025
2 conditions
2 sponsors
1 location
NCT06816186
The Impact of Multimedia Childbirth Prediction on Parturients and Their Spouses
NA
Recruiting
190 participants
Started: Feb 3, 2024 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT05912647
Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes
NA
Recruiting
376 participants
Started: Feb 3, 2024 · Completed: Dec 31, 2027
2 conditions
2 sponsors
1 location
NCT06216236
Effects of Physical Fitness Using a Kinect Interventional System
NA
Recruiting
60 participants
Started: Feb 3, 2024 · Completed: Oct 30, 2024
2 conditions
3 sponsors
2 locations
NCT06560086
Ketoconazole Contributes to Cryptorchidism Outcome Via Modulating Macrophage Trem2
NA
Recruiting
10 participants
Started: Feb 3, 2024 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05331534
Effect of Attentional Therapy on Post-traumatic Stress Disorder
NA
Recruiting
140 participants
Started: Feb 2, 2024 · Completed: Feb 2, 2029
1 condition
1 sponsor
1 location
NCT06246721
Attitude and Success Rate of Women with Pelvic Organ Prolapse on Self-management of Vaginal Pessary
NA
Recruiting
289 participants
Started: Feb 2, 2024 · Completed: Dec 15, 2025
1 condition
2 sponsors
1 location
NCT06256224
Toripalimab Combined With Definitive CCRT for LACC Patients
NA
Recruiting
150 participants
Started: Feb 2, 2024 · Completed: Dec 31, 2028
3 conditions
1 sponsor
1 location
NCT06563869
Sintilimab With Chemotherapy Plus PEG-rhG-GSF for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma
PHASE3
Recruiting
40 participants
Started: Feb 2, 2024 · Completed: Nov 22, 2026
1 condition
1 sponsor
1 location
NCT06337097
STRICT - Surveillance With TRoponin During Immune Checkpoint Therapy
NA
Recruiting
880 participants
Started: Feb 2, 2024 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT05968391
Acetoacetate and Acetate Metabolism in Patients With Chronic Kidney Failure.(RENO-TEP)
N/A
Recruiting
15 participants
Started: Feb 2, 2024 · Completed: Jun 15, 2025
1 condition
2 sponsors
1 location
NCT06092463
The Intestinal Innate Immune System in Newborns. Development and Inflammation in Health and Disease
N/A
Recruiting
275 participants
Started: Feb 2, 2024 · Completed: Oct 30, 2029
5 conditions
3 sponsors
2 locations
NCT06671886
NAFLD Clinical Care Pathway
NA
Recruiting
32 participants
Started: Feb 2, 2024 · Completed: Nov 13, 2028
2 conditions
1 sponsor
1 location
NCT05888428
Study of Efficacy of the MyoTrain System in a Population of Individuals With Trans-radial Limb Loss
NA
Recruiting
16 participants
Started: Feb 2, 2024 · Completed: Jan 31, 2026
2 conditions
4 sponsors
1 location
NCT05207085
Efficacy of Valbenazine for the Treatment of Trichotillomania in Adults
PHASE2
Recruiting
20 participants
Started: Feb 2, 2024 · Completed: Oct 15, 2026
1 condition
2 sponsors
1 location
NCT06062342
Five Point Initiative: A Bundled Implementation Strategy to Address the HIV Epidemic in Black Communities
NA
Recruiting
20,400 participants
Started: Feb 2, 2024 · Completed: Jun 30, 2029
1 condition
2 sponsors
1 location
NCT06220838
Study SC-101 in Subjects With Advanced Malignancies
PHASE1
Recruiting
100 participants
Started: Feb 2, 2024 · Completed: Sep 30, 2026
1 condition
1 sponsor
5 locations
NCT05962606
Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.
PHASE2
Recruiting
150 participants
Started: Feb 2, 2024 · Completed: Jun 30, 2026
1 condition
1 sponsor
28 locations
NCT06252545
Promoting CT Engagement for Pancreatic Cancer With App
NA
Recruiting
26 participants
Started: Feb 2, 2024 · Completed: Feb 1, 2027
1 condition
2 sponsors
2 locations
NCT06257017
Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma
PHASE2
Recruiting
20 participants
Started: Feb 2, 2024 · Completed: Dec 30, 2025
2 conditions
3 sponsors
1 location
NCT06035445
Support for Adolescents Living With HIV in South Africa
NA
Recruiting
1,000 participants
Started: Feb 2, 2024 · Completed: Dec 31, 2027
2 conditions
3 sponsors
1 location
NCT06097468
Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC)
PHASE1/PHASE2
Recruiting
40 participants
Started: Feb 2, 2024 · Completed: Sep 1, 2027
1 condition
3 sponsors
1 location
NCT06244719
Vibrotactile Stimulation for Upper-Extremity Stroke Rehabilitation
PHASE1
Recruiting
24 participants
Started: Feb 2, 2024 · Completed: Feb 2, 2025
1 condition
1 sponsor
2 locations
NCT06242847
Role of Insulin Action in Psoriasis Pathogenesis
N/A
Recruiting
18 participants
Started: Feb 2, 2024 · Completed: May 31, 2027
5 conditions
1 sponsor
1 location
NCT06299774
Emergency Care at Home
NA
Recruiting
1,500 participants
Started: Feb 2, 2024 · Completed: Mar 2, 2025
2 conditions
1 sponsor
1 location
NCT06285084
Deep Learning ECG Evaluation and Clinical Assessment for Competitive Sport Eligibility
N/A
Recruiting
531 participants
Started: Feb 2, 2024 · Completed: Feb 2, 2027
4 conditions
1 sponsor
1 location
NCT06611787
A Comprehensive Registry Study of the Whole Life Cycle of Patients With CHD
N/A
Recruiting
100,000 participants
Started: Feb 2, 2024 · Completed: Jan 1, 2030
1 condition
1 sponsor
1 location
NCT05987241
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
PHASE2/PHASE3
Recruiting
992 participants
Started: Feb 2, 2024 · Completed: Sep 2, 2030
7 conditions
1 sponsor
461 locations
NCT06253936
Prevalence of Anatomical Variants of Dural Sinuses by Magnetic Resonance Venography Evaluation in Sohag
N/A
Recruiting
169 participants
Started: Feb 2, 2024 · Completed: Sep 1, 2024
1 condition
1 sponsor
1 location
NCT06184464
Prostatic Size Reduction Following of Leuprorelin Acetate
N/A
Recruiting
40 participants
Started: Feb 2, 2024 · Completed: Dec 15, 2024
2 conditions
1 sponsor
1 location
NCT06253234
Safety and Efficacy Study for DC Vaccine in Recurrent or Progressive High-grade Gliomas
PHASE1
Recruiting
12 participants
Started: Feb 2, 2024 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT06365099
Identifying Personalized Brain States Predicting Residual Corticospinal Tract Output After Stroke
PHASE1
Recruiting
20 participants
Started: Feb 2, 2024 · Completed: Mar 31, 2026
1 condition
2 sponsors
1 location
Previous
1
More pages
585
586
587
588
589
590
591
More pages
1333
Next